Literature DB >> 7435512

Adverse reactions to nitrofurantoin. Analysis of 921 reports.

L Holmberg, G Boman, L E Böttiger, B Eriksson, R Spross, A Wessling.   

Abstract

Reports on adverse reactions to nitrofurantoin today are common in Sweden and constitute 10 to 12 percent of all incoming reports. We present an analysis of 921 reports of adverse reactions received by the Swedish Adverse Drug Reaction Committee during the period 1966--1976. The two largest groups consist of reports of acute pulmonary reactions (43 percent) and allergic reactions (42 percent). The remaining reports fall into any of four smaller groups, chronic pulmonary reactions, liver damage, blood dyscrasias or neuropathy. Acute pulmonary and acute allergic reactions in all aspects are very similar and carry the characteristics of an acute hypersensitivity reaction. The increasing number of reports--even in relation to sales figures--would be best explained by a continuous sensitization. Chronic pulmonary reactions (interstitial pneumonitis) afflict older patients, often after prolonged treatment with relatively small doses. We suggest that these reactions are elicited by a toxic mechanism. Seventy-one percent of all reactions were severe enough to cause the patient's hospitalization; only 1 percent was fatal. The risk of an adverse reaction varies with sex and age, increases with age and is higher in women than in men. The time has come for a re-evaluation of nitrofurantoin and its role in the treatment of urinary tract infections.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7435512     DOI: 10.1016/0002-9343(80)90443-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  45 in total

1.  Nitrofurantoin-induced pulmonary reaction involving respiratory symptoms: case report.

Authors:  Zahra Kanji; Victoria C H Su; Raj Mainra
Journal:  Can J Hosp Pharm       Date:  2011-09

2.  Nitrofurantoin-associated lung and liver toxicity leading to liver transplantation in a middle-aged patient.

Authors:  Tony K L Kiang; Jo-Ann Ford; Eric M Yoshida; Nilufar Partovi
Journal:  Can J Hosp Pharm       Date:  2011-07

Review 3.  Treatment of urinary infection in the elderly.

Authors:  M G Morgan; W Brumfitt; J M Hamilton-Miller
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

4.  Giant cell interstitial pneumonia associated with nitrofurantoin.

Authors:  Charles William Hargett; Thomas A Sporn; Victor L Roggli; John W Hollingsworth
Journal:  Lung       Date:  2006 May-Jun       Impact factor: 2.584

5.  Acute respiratory failure during pregnancy: a case of nitrofurantoin-induced pneumonitis.

Authors:  Aneez Mohamed; George K Dresser; Sanjay Mehta
Journal:  CMAJ       Date:  2007-01-30       Impact factor: 8.262

6.  Cluster-like headache attacks triggered by nitrofurantoin intake.

Authors:  Ilaria Casetta; Jay Guido Capone
Journal:  Eur J Clin Pharmacol       Date:  2013-10-22       Impact factor: 2.953

7.  Nitrofurantoin-induced interstitial pneumonitis: albeit rare, should not be missed.

Authors:  Haamid Syed; Ghassan Bachuwa; Sunil Upadhaya; Firas Abed
Journal:  BMJ Case Rep       Date:  2016-02-24

8.  Antimicrobial prescribing in nursing homes in Finland: results of three point prevalence surveys.

Authors:  M-L Rummukainen; T Kärki; M Kanerva; M Haapasaari; J Ollgren; O Lyytikäinen
Journal:  Infection       Date:  2012-09-17       Impact factor: 3.553

Review 9.  Drug allergy: an overview.

Authors:  R D DeSwarte
Journal:  Clin Rev Allergy       Date:  1986-05

10.  Nitrofurantoin-associated bronchiolitis obliterans organizing pneumonia: report of a case.

Authors:  Mark E Fenton; Rani Kanthan; Donald W Cockcroft
Journal:  Can Respir J       Date:  2008-09       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.